Obesity-induced insulin resistance results in chronic hyperinsulinemia that activates the insulin-like growth factor-1 (IGF-1) signaling pathway, stimulating PI3K/AKT and MAPK pathways independently of estrogen. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.